Cost analysis · Tirzepatide

Why compounded tirzepatide costs what it does

Compounded tirzepatide has a real cost structure, and understanding it is the best defence against both overpaying and against a price that is too good to be true. The floor in this database is $169 a month all-in.

What is in the price

Five things, roughly in order of size. The active pharmaceutical ingredient, sourced from an FDA-registered facility and tested on receipt. The sterile compounding itself, which requires cleanroom facilities, trained personnel and release testing on every lot. The prescriber's time, which is a licensed clinician in your state. Cold-chain shipping. And the supplies and instruction that make the vial usable.

None of those is free, and the sterile compounding in particular is expensive in a way that is not obvious from the outside — it is the part that a program cutting corners cuts.

Reading a price below the floor

When a program advertises materially below the field floor, there are only a few explanations, and they are worth distinguishing. It may be a genuine promotional rate, subsidised to acquire customers, with a published end date and a standard rate behind it. It may be a starting-dose price presented as a standing rate. It may exclude fees that appear later. Or the cost structure may genuinely be different in a way that warrants questions.

This site handles the first case by storing both rates and labelling the promotional one with its end date, and the second by refusing to rank a program with no published maintenance price at all.

Why the approved product costs more

The approved product carries the cost of the clinical trial programme that established it works, the regulatory review that approved it, and manufacturing held to approved-drug standards with FDA inspection behind it. Compounded product carries none of those costs — which is most of the price difference, and also most of the difference in what you are getting.

That is the honest framing of the gap: it is not that the same medicine is cheaper elsewhere. It is that a different, unreviewed product containing the same active molecule is cheaper, and the price difference is largely the review.

What a fair price question sounds like

Not "why is this more expensive than the cheapest" but "what does this include that the cheapest does not, and can you show me." Named pharmacy, release testing, supplies, clinician access and a published dose ladder are all real things a higher price can buy. A higher price that buys none of them is just a higher price.

Questions

Why does compounded tirzepatide cost what it does?

Active ingredient sourcing and testing, sterile compounding in cleanroom facilities with lot release testing, licensed prescriber time, cold-chain shipping, and injection supplies. The all-in floor in this database is $169 a month.

Why is compounded tirzepatide cheaper than Zepbound?

Because it carries none of the cost of the clinical trial programme, the regulatory review, or manufacturing held to approved-drug standards. The price difference is largely the review — which is also the difference in what you receive.

Should I be suspicious of a very low price?

It is worth understanding rather than assuming. It may be a labelled promotional rate, a starting-dose price presented as a standing one, or a figure excluding fees that appear later. Ask what the maintenance dose costs and what the standard rate is.